|
Q3 2024
|
25 |
1,304,499 |
NTRA, PCVX, CLDX, SNDX
|
13F-HR
|
11/14/2024 |
000108514624005812 |
|
Q2 2024
|
26 |
1,296,421 |
NTRA, VRTX puts, CLDX, SNDX
|
13F-HR
|
8/14/2024 |
000108514624003915 |
|
Q1 2024
|
23 |
955,475 |
NTRA, SNDX, CLDX, VERA
|
13F-HR
|
5/15/2024 |
000108514624002547 |
|
Q4 2023
|
24 |
902,614 |
NTRA, SNDX, CLDX, PCVX
|
13F-HR
|
2/14/2024 |
000108514624001322 |
|
Q3 2023
|
30 |
611,360 |
NTRA, CLDX, PCVX, SNDX
|
13F-HR
|
11/14/2023 |
000108514623004352 |
|
Q2 2023
|
26 |
727,067 |
NTRA, CLDX, ARGX puts, SNDX
|
13F-HR
|
8/14/2023 |
000108514623003327 |
|
Q1 2023
|
35 |
774,649 |
NTRA, HZNP, SNDX, CLDX
|
13F-HR
|
5/15/2023 |
000108514623002375 |
|
Q4 2022
|
31 |
651,905 |
HZNP, NTRA, CLDX, SNDX
|
13F-HR
|
2/14/2023 |
000108514623001182 |
|
Q3 2022
|
37 |
474,567 |
NTRA, SNDX, CLDX, VERA
|
13F-HR
|
11/14/2022 |
000108514622004005 |
|
Q2 2022
|
34 |
391,578 |
GLOBAL BLOOD THERAPEUTICS IN, SNDX, NTRA, CLDX
|
13F-HR
|
8/15/2022 |
000108514622003079 |
|
Q1 2022
|
33 |
308,277 |
GLOBAL BLOOD THERAPEUTICS IN, NTRA, SNDX, CLDX
|
13F-HR
|
5/13/2022 |
000108514622002058 |
|
Q4 2021
|
32 |
187,071 |
GLOBAL BLOOD THERAPEUTICS IN, XENE, SNDX, GOSS
|
13F-HR
|
2/14/2022 |
000108514622000941 |